My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Articles published by VantAI

VantAI and Halda Therapeutics Forge Alliance to Discover Next-Generation RIPTAC Medicines

August 19, 2025

From VantAI

Via Business Wire

VantAI Expands Strategic Collaboration with Blueprint Medicines to Advance Induced Proximity Drug Discovery

May 20, 2025

From VantAI

Via Business Wire

VantAI Launches Neo-1, the First AI Model to Rewire Molecular Interactions by Unifying Structure Prediction and Generation for Therapeutic Design

March 21, 2025

From VantAI

Via Business Wire

VantAI Expands Scientific Advisory Board with Leaders in Protein Design and Generative AI

May 22, 2024

From VantAI

Via Business Wire

VantAI Appoints John Cuozzo as Senior Vice President, Head of Drug Discovery

May 08, 2024

From VantAI

Via Business Wire

VantAI Collaborates With Google Cloud to Harness NVIDIA GPUs for Building Protein Interaction Foundation Models

May 01, 2024

From VantAI

Via Business Wire

VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence

February 13, 2024

From VantAI

Via Business Wire

VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer

February 07, 2024

From VantAI

Via Business Wire

VantAI Secures Renewed Support from Blueprint Medicines to Chart New Frontiers in Induced Proximity Drug Discovery

January 09, 2024

From VantAI

Via Business Wire

VantAI Announces Formation of Scientific Advisory Board

September 29, 2023

From VantAI

Via GlobeNewswire

Geometric Deep Learning Pioneer Michael Bronstein joins VantAI as Chief Scientist in Residence to Help Drive Artificial Intelligence Breakthroughs in Drug Discovery

July 27, 2023

From VantAI

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.